| Budget Amount *help |
¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
|---|
| Research Abstract |
In our results, the rate of prevalence of drug-resistant strains was as follows: ampicillin, 45.2%; cephalothin, 51.6%; cefotaxime, 12.1%; ceftazidime,5.4%; imipenem, 6.4%; gentamicin, 1.9%; amikacin, 1.6%; chloramphenicol, 10.8% ;tetracycline, 4.5%; ciprofloxacin, 1.3%. There was a local difference in drug resistance, and the variation of resistant bacteria tended to increase in an urban area.
|
